MAM
WPP acquires sports marketing agency Two Circles
MUMBAI: WPP has acquired a majority stake in London based sports marketing agency Two Circles.
Following the deal, Two Circles will become part of ESP Properties, GroupM’s newly launched company serving rights holders from the worlds of sports and entertainment.
Founded in 2011, Two Circles employs 55 people and works with leading sports rights holders across 10 markets internationally, enabling them to deliver the right messages to the right customers at the right time and in doing so, deliver commercial growth across all key revenue streams.
The agency’s clients include England and Wales Cricket Board, Valencia CF, Liverpool FC, Lawn Tennis Association, Ascot Racecourse, Harlequins, Bath and Wasps Rugby.
Two Circles will continue to operate as a stand-alone business within ESP Properties and be led by CEO Matt Rogan and managing director Gareth Balch. The agency’s consolidated revenues for the year ended 31 August, 2014 were ?2.7 million, with gross assets of ?1.0 million as at the same date.
This investment continues WPP’s strategy of developing its services in fast-growing and important markets and sectors and strengthening its digital capabilities. WPP’s digital revenues were $6.9billion in 2014, representing 36 per cent of the Group’s total revenues of $19billion. WPP has set a target of 40-45 per cent of revenue to be derived from digital in the next five years.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
